12. Bibliography
- 1. Barnett A. Miller M. Littlejohn G:A survival study of patients with scleroderma diagnosed over 30 years. The value of a simple coetaneous classification in the early stage of the disease. J Rheumatol 1988;15:276-283
- 2. Billet E. Piette E. Schmidt J. Lumineau J.P Gordeeff A: Sclérodermie circonscrite-localisation naso-labio-alvéolaire. Rev Stomatol Chir Maxillofac 1983;84;203-209
- 3. Blétry O. Guillevin L. Godeau P: Sclérodermie généralisée, acquisition récentes. Med Hyg1978;36:165-168
- 4. Blom-Bülow B. Sundström G. Jonson B. Tylen U. Wollheim F: Early changes in esophageal function in progressive systemic sclerosis: a comparison of manometry and radiology. Clin Physiol 1984;4:147-158
- 5. Botstein G. Leroy E: Primary heart disease in systemic sclerosis . Advances in clinical and pathological features, pathogenesis and new therapeutic approaches. Am Heart J 1981;102:913-919
- 6. Bramwell B: Diffuse scleroderma; its frequency; its occurrence in stonemasons. Edinb Med J, 1914;12:387-401
- 7. Bulkley B. Ridolfi R. Salyer W. Hutchins G: Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976;53:483-490
- 8. Callen P.Y: Oral manifestations of collagen vascular disease. Semin Cutan Med Surg, 1997;16:323-327
- 9. Campell PM. LeRoy EC: Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975;4:351-354
- 10. Cartier J. Beziat L: Les manifestations maxillo-faciales de la sclérodermie généralisée. Rev Stomatol Chir Maxillofac.1990;91:219-222
- 11. Clements P.Furst D. Campion D. Brhan A. Harris R. Levy J. Paulus H: Muscle disease in progressive systemic sclerosis. Diagnostic and therapeutic considerations. Arthritis Rheum 1978;21:62-71
- 12. Cohen S. Laufer I. Snape W. Shiau Y. Levine G. Jimenez S: The gasterointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology 1980;79:155-166
- 13. Cohen S. Johnson A. Hurd E: Cytotoxity of sera from patients with scleroderma. Effects on human endothelial cells and fibroblasts in culture. Arthritis Rheum 1983;26:170-178
- 14. Cowie R: Silica-dust-exposed mine workers with scleroderma. Chest 1987;92:260-262
- 15. Curizo C: Discussioni Anatomico-Pratiche di une raro, e stravagante morbo cutaneo in una giovane Donna felicemente curato in questo grande ospedale deglincurabili. Napoli presso givanni di simone 1753
- 16. D'Angelo W. Fries J. Masi A. Schulman L: Pathologic observations in systemic sclerosis. As study of 58 matched controls. Am J Med 1969;46:428-440
- 17. Davidsson RA: Impotence in progressive systemic sclerosis. Ann Intern Med 1982;96:125-126
- 18. Erasmus LD: scleroderma in gold miners on the witwaterrand with particular reference to pulmonary manifestations. S Afr Lab Clin Med 1957; 3:209-231
- 19. Eversole LR.Jacobsen PL.Stone CE: Oral and gingival changes in systemic sclerosis. J Periodontol 1984;55 175-178
- 20. Farmer RG. Giffors RWJ. Hines EAJ: Prognostic significance of Reynaud's phenomenon and other clinical characteristics of systemic scleroderma.Circulation 1980;21:1088-1095
- 21. Fiessinger J.N. Blanchet-Bardon C. Drouillat J-P. Camilleri J-P. Housset E . Rapports entre la sclérodermie et le syndrome de Sjögren. Presse Med 1975;45;4:3177-3180
- 22. Fleishmajer R. Perlish J. Reeves J: Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977;20:975-984
- 23. Follandsbee W. Curtiss E. Medsger T. Steen V. Uretsky B. Owens G. Rodnan G: Physiological abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984;310:142-148
- 24. Follandsbee W. Curtiss E. Rahko P. Medsger JrT. Lavine S. Owens G. Steen V: The electrocardiogram in systemic sclerosis. Am J Cardiol 1985;79:183-192
- 25. Follandsbee W: The cardiovascular manifestations of systemic sclerosis. Curr Probl Cardiol 1986;5:242-298
- 26. Gilliland B.C: Sclérodermie systémique. In Textbook of T.R Harrison Principes de Médicine Interne. 5e ed.fr. 1992;271:1443-1448pp
- 27. Gintrac M. Note sur la sclérodermie. Rev Med Chir. (Paris) 1847;2:263-267
- 28. Giordano M. Capelli L. Tirri G. Valti M. Vorschlag zu einer neuen Klassifizerung und nomenklature der progredienten generaliserten Sklerodermie. Verh Dtsch Ges Rheumatol 1980;6:379-382
- 29. Giordano M. Valentini G. Migliaresi S. Picillo U. Vatti M: Different antibody patterns and different prognosis in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 1986;13:911-916
- 30. Goetz R. Pathology of progressive systemic sclerosis with special reference to changes in the viscera. Clin Proc 1945;4:337-392
- 31. Green D. Scleroderma and its oral manifestations. Oral Surg Oral Med Oral Pathol 1972;15:1312-1318
- 32. Gustafsson R: Captopril effect on SSc. Ph.D thesis, Centraltryckeriet, Uppsala, 1992
- 33. Jensen J. Sindet-Pedersen S: Osseointigrated implants for prosthetic reconstruction in a patient with scleroderma. Report of a case. J Oral Maxillofac Surg 1990;48:739-741
- 34. Kahaleh M. Sherer G. LeRoy E: Endothelial injury in scleroderma. J Exp Med 1979;149:1326-1335
- 35. Kahan I. Jefferies G. Sleisenger M. Malabsorbtion in intestinal scleroderma. Correction by antibiotics. N Engl J Med 1966;274:1339-1344
- 36. Kawakami T, Soma Y: Immunohistochemical expression of transforming growth factor ß in calcinosis in a patient with systemic sclerosis and CREST syndrome. Br J Derm 2001, 1098-1131
- 37. Kazandjian S. Fiessinger J. Mignot J. Vayssairat M. Camilleri J.P. Housset E. Quantification de la sclérose des glandes salivaires labiales au cours de la sclérodermie généralisée. Presse Med 1981;10:317-323
- 38. Keystone E. Lau C. Gladman D. Wilkinson S. Lee P. Shore A: Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies. Clin Exp Immunol 1982;48:443-448
- 39. Klareskog L. Gustafsson R. Scheynius A. Hällgren R: Increased expression of PDGF B-type receptors in the dermal lesions of systemic sclerosis. Arthritis Rheum 1990; 30:1534-1541
- 40. Kunmagi Y. Shiokawa Y. MedsgerTJ. Rodnan G: Clinical spectrum of connective tissue disease after cosmetic surgery. Arthritis Rheum 1984;28:1-12
- 41. König G. Ludersmith C. Hammer C. Adelmann Grill B. Braun-Falco O. Fruhmann G: Lung involvement in scleroderma. Chest 1984;85:318-324
- 42. Lapenas D. Rodnan G. Cavallo T: Immunopathology of the renal vascular lesions of progressive systemic sclerosis. Am J Pathol 1978;91:243-258
- 43. Leinwand I. Duryee A. Richter M: Scleroderma. Ann Intern Med 1954;41:1003-1041
- 44. LeRoy E. Connective tissue disease characterized by fibrosis. In Textbook of rheumatology. Kelly W, Harris E, Ruddy S, Eds. WB Saunders, Philadelphia 1985, pp 1183-1205.
- 45. LeRoy EC. Black C. Fleishmayer R: Scleroderma (systemic sclerosis): classification, subset and pathogenesis. J Rheumatol 1988;15:202-208
- 46. Lever W. Schaumberg-Lever G. Jaworsky C: In Histophatology of the skin. 8th ed. J.B Lippincott Company,Philadelphia 1997, pp 253-282
- 47. Lopez J: Surgical management of microstomia in the dental office. JADA 1978;33:65-67
- 48. Mackel A. DeLustro F. DeLustro B. Fudenberg H. LeRoy E: Immune response to connective tissue components of the basal membrane. Connect Tissue Res 1982;10:333-343
- 49. Manoussakis M. Constantopoulos S. Ghavari A. Mountsopoulos H: Pulmonary involvement in systemic sclerosis. Association with anti-Scl 70 antibody and digital pitting. Chest 1987;92:509-513
- 50. Maricq H. LeRoy E. D'Angelo W. Medsger T. Rodnan G. Sharp G. Wolfe J: Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980;23:183-189
- 51. Marmary Y, Glaiss R. Pisanty S: Scleroderma: oral manifestations. J Oral Surg, 1981;52:32-37
- 52. Matsui S: über die pathologie und pathogenese von sklerodermia universalis. Mitt Med Fakult Kaiserl 1924;31:55
- 53. McGiven A. DeBoer W. Barnet A: Renal immune deposits in scleroderma. Pathology 1971;3:145-150
- 54. McWorter J. LeRoy E. Pericardial disease in scleroderma. Am J Med 1974;57:566-575
- 55. Medsger TA: Systemic sclerosis (scleroderma), localized forms of scleroderma and calcinosis, In: Arthritis and allied conditions D.J Koopeman Ed, 1993 pp 372-378
- 56. Medsger TA. Masi AT: Epidemiology of systemic sclerosis. Ann Intern Med, 1971;74:714-721
- 57. Medsger TA: Systemic sclerosis, eosinophilic fasciitis and calcinosis. In Arthritis and allied conditions. A textbook of rheumathology. McCarty D, Ed. Lea &Febiger, Philadelphia 1985, pp 994-1036
- 58. Medsger TA. Masi A: Epidemiology of progressiive systemic sclerosis. Clin Rheum Dis 1979;5:15-25
- 59. Medsger Jr T. Rodnan G. Benedek T. Robinson H. Survival with systemic sclerosis. A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971;75:369-376
- 60. Medsger Jr T: Progressive systemic sclerosis. Skeletal muscle involvement. Clin Rheum Dis 1979;5:103-113
- 61. Myers A. Progressive systemic sclerosis. Gastrointestinal involvement. Clin Rheum Dis. 1979:115-129
- 62. Nagy G. Kovacs J. Zeher M: Analysis of the oral manifestations of systemic sclerosis.Oral Surg Oral Med Oral Pathol 1994;77:141-146
- 63. Nancy R: CREST syndrome: clinical Manifestation and dental management: J Prosth 1998,7:155-161
- 64. Nan Weiner S. Wolf M: Changes in the mandible in scleroderma. Oral Surg 1981;3:329-330
- 65. Naylor WP: Oral Management of the scleroderma patient. JADA 1982;105:814-817
- 66. Naylor P. Douglass C. Mix E: The non surgical treatment of microstomia in scleroderma. A pilot study. Oral Surg Oral Med Oral Pathol 1984;5:508-511
- 67. Oram S. Stokes W: The heart in scleroderma. Br Heart J 1961;23:243-259
- 68. Orringer M. Dabich L. Zarafonetics C. Sloan H: Gastroesophagal reflux in esophageal scleroderma. Diagnosis and implications. Ann Thorac Surg 1976;22:120-130
- 69. Owens G. Fino G. Herbert D. Steen V. Medsger TJ. Pennock B. Cotrell J. Rodnan G. Rodgers R: Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. Chest 1983;84:546-550
- 70. Owens G. Medsger T: Systemic sclerosis secondary to occupational exposure. Am J Med 1988;85:114-116
- 71. Piero C. Rivaroli A. Vetrano S: Progressive systemic sclerosis: rare localization of the maxillofacial district. J Cranofacial Surg 1998:9;5:472-476
- 72. Puissant A: Sclérodermie In Dermatologie et vénéréologie Saurat J.-H, Grosshans E, Laugier P, Lachapelle J.M. Eds 2eme ed. Masson, Paris 1991, pp 327-338
- 73. Rodnan GP. Benedek TG. Medsger TA. Cammarata PJ: The association of progressive systemic sclerosis with coal miners pneumoconiosis and other forms of silicosis. Ann Intern Med 1967;66:323-334
- 74. Rodnan G. Benedek T: An historical account of the study of progressive systemic sclerosis. Ann Intern Med 1962;57:305-319
- 75. Rodnan G: Progressive systemic sclerosis. In Arthritis and allied conditions, 8th ed. Hollander JL, McCarty, DJ jr, Eds. Lea & Febiger, Philadelphia 1972,
- 76. Rodnan G. Jablonska S. Medsger T: Classification and nomenclature of progressive systemic sclerosis. Clin Rheum Dis 1976;5:5-13
- 77. Roum A. Whiteside T. Medsger Jr T. Rodnan G: Lymphocytes in the skin of patients with systemic sclerosis. Arthritis Rheum 1984;27:645-653
- 78. Sackner M. Akgun N. Kimberly P. Lewis D: The pathophysiology of scleroderma involving the heart and respiratory system. Ann Intern Med 1964;60:611-630
- 79. Sackner M. Heinz E. Steinberg A: The heart in scleroderma. Am J Cardiol 1966;17:542-559
- 80. Salen G. Goldstein F. Wirits C: Malabsorption in intestinal scleroderma. Relation to bacteria flora and treatment with antibiotics. Ann Intern Med 1966;64:834-841
- 81. Salerni R. Rodnan G. Leon D. Shaver J: Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis. Ann Intern Med 1977;86:394-399
- 82. Schaefer R. Hheidland A: Captopril indication and clinical problems. Contr Nephrol 1984;43:182-203
- 83. Smith D.B: Scleroderma: its oral manifestations. Oral Surg, 1958;11:865-869
- 84. Spain D Tomas A: Pulmonary manifestations of scleroderma: Anatomic-physiological correlation. Ann Intern Med 1950;32:152-161
- 85. Spielvogel R. Goltz R. Kersey J: Scleroderma like changes in chronic grafts vs host disease. Arch Dermatol 1977;113:1424-1428
- 86. Steen V.D: Clinical manifestations of systemic sclerosis. Semin Cutan Med Surg, 1998;17:1:48-54
- 87. Steen V. Powell D. Medsger TJ: Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203
- 88. Subcommittee for scleroderma: Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 1980;23:581-589
- 89. Tan E. Rodnan G. Garcia I. Morio Y. Fitzler M. Peebles C: Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationships to CREST syndrome. Arthritis Rheum 1980;23:617-625
- 90. Takehara K. Moroi Y: Antinuclear antibodies in the relatives of patients with systemic sclerosis. Br J Dermatol 1985;112:23-33
- 91. Torres J. Sanchez J.L: Histopathologic differentiation between localized and systemic scleroderma. Am J Dermatol 1998;20:242-245
- 92. Traub Y. Shapiro A. Rodnan G. Medsger T. Mc Donald R. Steen V. Osial T. Tolchin S: Hypertension and renal failure in progressive systemic sclerosis. Review of a 25 year experience with 68 cases. Medicine 1983;62:335-352
- 93. Trell E. Lindström C. Pulmonary hypertension in systemic sclerosis. Ann Rheum Dis 1971;30:390-400
- 94. Weisman RA. Calcaterra TC: Head and neck manifestations of scleroderma. Ann Otol 1978;87:332-339
- 95. Whitman H. Case D. Laragh J. Christian G H. Botstein G. Maricq H. LeRoy E: Variable response to oral angiotensin- converting enzyme blockade in hypertensive scleroderma patients. Arthritis Rheum 1982;25:241-248
- 96. Winkelmann R: Pathogensis and staging of scleroderma. Acta Dermatol Venerol 1976;56:83-92
- 97. Winterbauer R:l Multiple telangiectasia, Raynaud's phenomenon, sclerodactyly and subcutaneous calcinosis. Bull Johns Hopkins Hosp 1964;114:361-383
- 98. Wood R. Lee P: Analysis of the oral manifestations of systemic sclerosis. Oral Surg Oral Med Oral Pathol, 1988;65,2:172-177
- 99. Young R: Mark G. Pulmonary vascular changes in scleroderma. Am J Med 1978;64:998-1004
- 100. Ziegler V: Haustein UF. MelhornJ: Qurtzinduzierte sklerodermie. Sklerodermie ähnliches syndrom oder echte progressive sklcerodermie? Dermatol Monatsschr 1986;172:86-90
- 101. Zschunke E, Ziegler V, Haustein U. Occupationally induced connective tissue disorders in textbook of Occupational skin disease, Robert M. Adams 2nd ed. W.B Saunders 1990 pp 172-181
[Previous]